Tuesday's Google Doodle honors the first woman admitted as a student at Harvard Medical School and the founder of the first pediatric hospital in the Philippines.
News & Features
A medical device supplier is recalling certain lots of its temporary bipolar pacing leads that are used in conjunction with a compatible external pulse generator for the temporary pacing and sensing of the heart.
Zimmer Biomet initiated the recall due to the lack of adequate validation and controls to ensure that final products were clean and free from bacteria and chemical residue.
FDA is taking what it calls "transformative new steps" to modernize the agency's 510(k) program to keep pace with the increasing complexity of rapidly evolving medical technology.
AdvaMed has taken issue with the investigative report, arguing that it fails to look at both the challenges and the accomplishments of the medical device industry.
The Dublin-based company will pick up Nutrino, a frequent collaborator and a company that uses artificial intelligence for nutrition-related services.
Right now we’re in the middle of the Artificial Intelligence Renaissance for medtech. But what does this mean for companies? Is this a fad or is AI here to stay in medtech. MD+DI Managing Editor Omar Ford gives his thoughts on this emerging trend.
Doctors need more tools to quickly determine whether an antibiotic is truly needed, an expert tells MD+DI.
A startup spawned from Oxford University is trying to commercialize components of a quantum computing technology that could ultimately improve the downstream end of existing diagnostic devices.
RenalytixAI has raised $29 million to help advance tests for early detection of kidney disease and a test that will help in the accurate management of kidney transplant rejection.
The Marlborough, MA-based company hasn’t been shy about building up its portfolio through M&A, the only question now is can it slip in another deal before the end of the year.